About 500 reports

  • Global Kaposi sarcoma HAART therapy market 2016-2021 ($ millions)
  • MARKET DRIVERS
  • Cancer
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

However, the region holds strong potential due to hundreds of clinical trials being performed in the region, more specifically in the US, for the treatment of cancer, HIV/ AIDS, and other diseases.

  • Cancer
  • Gene Therapy
  • China
  • Forecast
  • Celgene Corporation
  • Cervical Cancer Diagnostics Market: Product Outlook

AIDS Acquired immune deficiency syndrome ##.

  • Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.

HIV/ AIDS Sero-Behavioural Survey 2004-##; Vietnam Population and AIDS Indicator Survey; Zambia Demographic and Health Survey 2001-2002; Zimbabwe Demographic and Health Survey 2005-##. ##.

  • Cancer
  • Sexually Transmitted Disease
  • Asia
  • Europe
  • Forecast

Biopharmaceuticals have also reduced the number of deaths caused due to cancer and HIV/ AIDS in the last decade which has led to increase the adoption of biopharmaceuticals in the global market.

  • Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • 11.3 Factors that Impede Market Growth

Bowel wall perforation or tears Bleeding Infection and other blood-borne diseases such as hepatitis, HIV, and AIDS can be transmitted from one individual to the other if sterilization is not done properly.

  • Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation

BMS DRUGS PORTFOLIO INCLUDE MEDICINES THAT TREAT CANCER, CARDIOVASCULAR DISEASE, HEPATITIS B AND HEPATITIS C, HIV/ AIDS, RHEUMATOID ARTHRITIS AND DERMATOLOGY.

  • Cancer
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • TREATMENT USAGE RATES
  • CANCER VACCINES MARKET, MAJOR MARKETS, TREATMENT USAGE PATTERNS FOR CERVICAL CANCER,
  • Cancer
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

HIV/ AIDS, Tuberculosis (TB) remains a global public health problem and is one of the three leading causes of deaths worldwide due to infectious diseases.

  • Cancer
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

The high prevalence of HIV/ AIDS in South Africa is seen as the key factor in the low life expectancy, which is impeding the development of the country, affecting maintenance of healthcare services, as well as the provision of medical genetic services.

  • Cancer
  • World
  • Forecast
  • Cepheid
  • Transgenomic, Inc.

Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Cervical cancer is one of the most common causes of cancer death for North American women.

  • Cancer
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • North America
  • Forecast

Disease control efforts for viral Hepatitis, Tuberculosis and HIV/ AIDS remain important issues for China.

  • Breast Cancer
  • Cancer
  • Asia
  • China
  • OriGene Technologies, Inc.

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.

However, Africa is the major market for infectious diseases because of increased prevalence of UTIs and HIV.

  • Cancer
  • Hospital
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Cancer
  • In Vitro Diagnostic Reagent
  • Mortality
  • Asia
  • Forecast

A biotechnology company that develops vaccines for the functional cure of HIV.

  • Cancer
  • Cervical Cancer
  • Vaccine
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.
  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbidities for NHL
  • Cancer
  • Germany
  • Japan
  • Spain
  • Forecast

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

CURRENT IMMUNE MEDIATED DISEASE FOCUS MORE ON HIV/ AIDS, TUBERCULOSIS, PNEUMONIA, ENTERIC DISEASES AND MALARIA.

  • Cancer
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • BRISTOL-MYERS SQUIBB COMPANY
  • Cancer
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

HIV Test Data were not scrambled, and are therefore not available for analysis; Bolivia Encuesta Nacional de Demografia y Salud 2003; Burkina Faso Demographic and Health Survey 2003; Cambodia Demographic and Health Survey 2005; Cameroon Demographic and Health Survey 2004; Congo Enquete Demo

  • Cancer
  • In Vitro Diagnostics
  • Asia
  • Europe
  • Forecast

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • China
  • Japan
  • United States
  • Forecast

The 2008 reauthorization of PEPFAR expanded the U. S. commitment to US$ ## Billion over ## years to combat HIV/ AIDS, Tuberculosis, and Malaria.

  • Cancer
  • North America
  • United States
  • Cepheid
  • Myriad Genetics, Inc.

They' re striving toward this goal through public/ private partnerships like SECURE THE FUTURE, their pioneering $## million HIV/ AIDS program in Africa, and through their patient assistance programs.

  • Cancer
  • China
  • Bristol-Myers Squibb China Inc Ltd
  • Sanofi-Synthelabo Inc.
  • Schering-Plough Corporation

It concentrates its R& D efforts in the area of diseases with significant unmet medical needs: HIV/ AIDS, oncology, hepatitis, immunologic disorders, and cardiovascular and fibrotic disease.

  • Cancer
  • Arbor Pharmaceuticals, LLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

Prior to joining GlobalData, Natasha worked as an epidemiologist for three years in the HIV/ AIDS Surveillance Program at the Massachusetts Department of Public Health (MDPH).

  • Cancer
  • Australia
  • United States
  • World
  • Forecast

HE HAS EXPERIENCE IN DESIGNING AND EXECUTING AN OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Cancer
  • Canada
  • Italy
  • Spain
  • Forecast

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Cancer
  • Japan
  • United Kingdom
  • United States
  • Forecast

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Cancer
  • Japan
  • United Kingdom
  • United States
  • Forecast